Coronavirus updates | ‘Need complete knowledge’: DCGI puts SII, Bharat Biotech vaccine approval requests on hold
[ad_1]
India’s look ahead to a locally-produced coronavirus vaccine has gotten longer after an skilled committee of the Drug Controller General of India (DCGI) put Serum Institute’s and Bharat Biotech’s functions on hold, citing lack of complete knowledge.
Pfizer-BioNTech — whose vaccine has been authorised to be used within the United Kingdom and Bahrain — had utilized to Indian regulators earlier than SII and Bharat Biotech, and was scheduled to current its knowledge to the committee however didn’t flip up, the supply added.
You can observe coronavirus instances, deaths and testing charges on the nationwide and State ranges right here. A listing of State Helpline numbers is offered as properly.
Here are the most recent updates:
Maharashtra
Maharashtra identifies three teams for receiving COVID-19 vaccine on precedence
The Maharashtra authorities has determined to present precedence to well being employees from authorities and personal hospitals, every day wage employees, and people employed with built-in little one growth companies for the soon-to-be-made-available vaccine on COVID-19.
“The process of vaccination will run like a voting procedure. Booths will be set up and only those who are registered will be allowed to enter, along with an identity card. The person concerned will get a message on their phone and a certificate with QR code on completion of vaccination,” stated an official.
Vaccine
COVID-19 vaccine to have differential pricing: Pfizer
Global pharma main Pfizer has stated it can have differential pricing on its COVID-19 vaccine for various nations, as the corporate goals to make the vaccine obtainable the world over.
“The fundamental that went into the pricing was that we make sure we make it very quickly available to everyone,” stated Pfizer Inc Chairman and CEO Albert Bourla.
“We are having a tier pricing. It is one price for the developed world based on their GDP, another price, lower for the middle-income countries and in the low-income countries, like countries in Africa etc we are giving it on a not-on-profit base,” he added. Even in developed nations, the value is what they’ll afford to pay. In the U.S. the value is $19.50, the value of a mean meal, Mr. Bourla stated.
[ad_2]
